Lynk Pharmaceuticals
PrivateLast Round
Series C
Extension
Sep 21, 2023
Est. Valuation
$467.6M
Total Funding Raised
$154.95M
Company Overview
Lynk Pharmaceuticals is a clinical-stage biotechnology company that develops innovative small molecule drugs to treat tumors, autoimmune diseases, and inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lynk Pharmaceuticals Comparables
Compare Lynk Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alumis | 84% | |
| Sareum Holdings plc | 78% | |
| Aclaris Therapeutics | 77% | |
Lynk Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 21, 2023 | ||||
| Series C | May 31, 2023 | ||||
| Series B | Aug 27, 2021 | ||||
| Series A Extension | Dec 1, 2020 | ||||
| Series A Extension | Dec 1, 2020 | ||||
Series A | Jan 1, 2020 |
Key People
Founding team and executive leadership
Lynk Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series C Extension, Series B |
| Kaitai Capital | Angel, Seed, Series A |
| 健壹资本 | Angel, Seed |
| Tailong Investment | Series C |
| Legend Capital | Series B, Series A Extension |
| Howbuy Primary Fund | Series C Extension |
| Liando Investment | Series C Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Preparing for NDA submission and international audits.
- Sep 21, 2023
$17M round led by China Grand Prosperity Investment.
Lynk Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |